Agentix Corp. (AGTX)

OTCMKTS · Delayed Price · Currency is USD
0.0380
-0.0059 (-13.44%)
Apr 28, 2026, 4:00 PM EST
-24.00%
Market Cap 1.52M
Revenue (ttm) n/a
Net Income (ttm) -590.29K
Shares Out 40.07M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,625
Average Volume 13,650
Open 0.0380
Previous Close 0.0439
Day's Range 0.0380 - 0.0380
52-Week Range 0.0165 - 0.0550
Beta 1.00
RSI 41.06
Earnings Date Jul 14, 2026

About Agentix

Agentix Corp., a clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States. It develops AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, which has demonstrated efficacy in animal models of obesity and non-alcoholic fatty liver diseases. The company was formerly known as FairWind Energy, ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2020
Country United States
Stock Exchange OTCMKTS
Ticker Symbol AGTX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.